Searchable abstracts of presentations at key conferences in endocrinology

ea0090p418 | Pituitary and Neuroendocrinology | ECE2023

Search for new biomarkers of adult growth hormone deficiency metabolic syndrome: a comprehensive overview of a four peptides analysis

Mancini Antonio , Vergani Edoardo , Bruno Carmine , Oliva Alessandro , Curro Diego

Adult growth hormone deficiency (aGHD) is characterized by an altered metabolic profile and increased cardiovascular risk. Neudesin is a newly discovered protein mainly secreted from adipose tissue and brain, under evaluation for its possible activity as negative regulator of energy expenditure. Liver expressed antimicrobial peptide (LEAP)-2 is a competitive antagonist of ghrelin on its receptor. Spexin is a polypeptide related to the galanin-kisspeptin family, secreted along ...

ea0090ep585 | Endocrine-related Cancer | ECE2023

Phenotypic presentation of MEN1 (NM_130799.2):c.758delC (p.Ser253CysfsTer28) rs1592648765 pathogenic mutation of MEN-1 gene: a case report

Vergani Edoardo , Concolino Paola , Traini Emanuela , Macis Giuseppe , Mancini Antonio

Multiple endocrine neoplasia (MEN) 1 is a rare hereditary autosomal dominant tumor syndrome characterized by two or more endocrine tumors. Non-endocrine neoplasms have been described as well. MEN1 is caused by inactivating mutations of the onco-suppressor gene MEN-1 (chromosome 11q13) which encodes the protein menin. Currently, 897 public variants of MEN-1 gene are reported. We present the case of a recently discovered pathogenic mutations of MEN-1 gene. A 32-year-old Italian ...

ea0075p08 | Pituitary and neuroendocrinology | EYES2021

Indexes of chronic low-grade inflammation in different models of insulin-resistance: Evaluation of lipocalin-2 in metabolic sindrome, partial and total growth hormone deficiency

Bruno Carmine , Vergani Edoardo , Curro Diego , Pontecorvi Alfredo , Mancini Antonio

Lipocalin-2 (LCN2) is a glycoprotein synthetized by various cell types, including neutrophils, that acts as siderophores scavenger and play an important role in different chronic inflammatory processes. Metabolic Syndrome (MetS) and Adult Growth Hormone Deficiency (AGHD), both partial and total, are characterized by inflammatory features. The objectives of our cross-sectional study were: 1) to compare LCN2 levels in these clinical pictures; 2) to evaluate the relations between...

ea0075p10 | Pituitary and neuroendocrinology | EYES2021

Hormonal adjustment to metabolic derangement in adult Growth Hormone Deficiency: evaluation of Ghrelin and LEAP-2 serum level

Vergani Edoardo , Bruno Carmine , Curro Diego , Pontecorvi Alfredo , Mancini Antonio

Background: Ghrelin and its endogenous antagonist liver-expressed antimicrobial peptide-2 (LEAP-2) are involved in GH secretion, both acting on GSH-r1α, and regulation of glucose and lipids metabolism. Metabolic impairments are often accompanied by an upregulation of LEAP-2 expression, with a usual concomitant reduction in ghrelin secretion. Adult growth hormone deficiency (aGHD), characterized by weight gain, increased fat mass and insulin resistance, represent a conditi...

ea0081ep677 | Pituitary and Neuroendocrinology | ECE2022

Role of new peptide biomarkers in metabolic profiling of adult growth hormone deficiency patients: preliminary data on neudesin and its relationship with LEAP-2

Vergani Edoardo , Bruno Carmine , Gavotti Cesare , Oliva Alessandro , Curro Diego , Mancini Antonio

Patients affected by adult growth hormone deficiency (aGHD) show worse metabolic profile, with insulin-resistance, increased total cholesterol, LDL, triglycerides, reduced HDL, and higher risk of developing type 2 diabetes mellitus and cardiovascular complications. Adult GHD and metabolic syndrome (MetS) are closely related to each other, since they share the previous depicted clinical features, while obese MetS patients display lower IGF-1 levels due to a functional reduction...

ea0070aep751 | Pituitary and Neuroendocrinology | ECE2020

Evaluation of haemolitic complement activity (ch50) and igg subclasses in adult growth hormone deficiency: Preliminary data

Vergani Edoardo , Bruno Carmine , Basile Umberto , Napodano Cecilia , Piunno Gaia , Stefanile Annunziata , Gulli Francesca , Mancini Antonio

Adult Growth Hormone Deficiency (GHD) is a condition characterized by low grade chronic inflammation; increased levels of free light chains of immunoglobulins have been described; moreover, it shares some features with metabolic syndrome (MetS), including insulin resistance and oxidative stress, but with a different pattern of antioxidant response. Finally, it is known that GH, directly or via IGF-1 activity, influences many aspects of immune response; both humoral and cellula...

ea0063p694 | Pituitary and Neuroendocrinology 2 | ECE2019

New markers of systemic inflammation and oxidative macromolecular damage in partial and total Adult Growth Hormone Deficiency

Bruno Carmine , Vergani Edoardo , Brunetti Alessandro , Guidi Francesco , Angelini Flavia , Meucci Elisabetta , Silvestrini Andrea , Basile Umberto , Mancini Antonio

It is known that adult growth hormone deficiency (GHD) is associated with oxidative stress (OS): both GH and IGF-1 exert antioxidant functions. OS is in turn related to systemic inflammation and cardiovascular/oncological risk. Discordant data concerning GH effects on antioxidants are reported. Moreover, no data are available in partial GHD, which can induce cardiovascular alterations. To evaluate oxidative damage on macromolecules and systemic inflammation, 80 patients, studi...

ea0056gp66 | Cardiovascular | ECE2018

Evaluation of irisin levels in chronic heart failure with preserved or reduced ejection fraction

Mancini Antonio , Silvestrini Andrea , Bruno Carmine , Vergani Edoardo , Brunetti Alessandro , Favuzzi Angela Maria Rita , Guidi Francesco , Meucci Elisabetta , Mordente Alvaro

Background: The recently discovered myokin Irisin, a peptide originated by a proteolytic cleavage of the transmembrane protein fibronectin type III domain containing 5 (FNDC5) whose expression is induced by exercise and/or by increasing peroxisome proliferator-activated receptor (PPAR)-γ co-activator 1α (PGC-1α), has been considered a prognostic factor in Chronic Ischemic Cardiomyopathy and Acute Heart Failure. Nevertheless, no data are available on Irisin level...

ea0056p626 | Cardiovascular Endocrinology and Lipid Metabolism | ECE2018

Multi-hormonal deficits in heart failure with preserved ejection Fraction: prevalence and impact on diastolic dysfunction

Bruno Carmine , Favuzzi Angela Maria Rita , Vergani Edoardo , Venuti Angela , Nicolazzi Maria Anna , Fuorlo Mariella , Landolfi Raffaele , Mancini Antonio

Background: In heart failure with reduced ejection fraction (HFrEF), catabolic mechanisms have a strong negative impact on morbidity and mortality. The relationship between anabolic hormonal deficit, thyroid function and heart failure with preserved ejection fraction (HFpEF) has still been poorly investigated. For this reason, we tried to define the prevalence of multi-hormonal deficiencies in HFpEF patients and the relationships between hormonal deficits and echocardiographic...

ea0073pep4.2 | Presented ePosters 4: Reproductive and Developmental Endocrinology | ECE2021

Immunological and inflammatory biomarkers in non-obese patients affected by PCOS, correlation between hormonal and metabolic parameters: preliminary data

Bruno Carmine , Vergani Edoardo , Napodano Cecilia , Pocino Krizia , Stefanile Annunziata , Gulli Francesca , Oliva Alessandro , Basile Umberto , Mancini Antonio

ObjectivePolicystic ovary syndrome (PCOS) is a multifactorial disease characterized by reproductive and metabolic impairments. PCOS patients could present anovulation, hirsutism and infertility as well as higher prevalence of metabolic syndrome, glucose intolerance and diabetes. Insulin-resistance (IR) together with hyperandrogenism represent the main players, with reciprocal influences in a vicious circle: insulin promotes androgen secretion in thecal c...